Vanda Pharmaceuticals Reports Fourth Quarter 2015 and Full Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St futures muted; Mideast talks, US-China summit in focus
- Activist Jana Partners calls for Six Flags sale - WSJ
- Oil holds near two-week lows while diesel cracks hit record peak
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
Vanda Pharmaceuticals (VNDA) Misses Q4 EPS by 9c, Offers Guidance
February 10, 2016 4:51 PM ESTVanda Pharmaceuticals (NASDAQ: VNDA) reported Q4 EPS of ($0.35), $0.09 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $31.85 million versus the consensus estimate of $31.34 million.
2016 Financial Guidance
Vanda expects to achieve the following financial objectives in 2016:
Net product... More